Last updated on November 2016

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)


Brief description of study

The purpose of this study is to investigate the superiority of KPS-0373 to placebo, and evaluate the safety of KPS-0373 in SCD patients.

Clinical Study Identifier: NCT02889302

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kissei Pharmaceutical Co., Ltd

Tokyo and Other Japanese City, Japan
  Connect »